Mar 2, 2026 07:30AM
Mar 2, 2026 07:30AM
Dec 31, 2025 07:00AM
Dec 31, 2025 07:00AM
Nov 21, 2025 03:56AM
Nov 21, 2025 12:25AM
Nov 13, 2025 04:05PM BioAtla Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
Oct 23, 2025 08:02AM
Oct 23, 2025 08:00AM
Sep 9, 2025 04:02AM
Sep 8, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 7, 2025 04:05PM
Jun 2, 2025 08:07AM BioAtla (BCAB) Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Jun 2, 2025 08:00AM
May 6, 2025 04:05PM
Mar 27, 2025 04:05PM
Dec 16, 2024 08:00AM
Nov 13, 2024 06:51AM
Nov 7, 2024 04:01PM
Sep 23, 2024 07:31AM BioAtla (BCAB) and Context Therapeutics (CNTX) Announce Exclusive Worldwide License Agreement to Develop and Commercialize BA3362
Sep 23, 2024 07:30AM
Sep 16, 2024 08:01AM
Sep 16, 2024 08:00AM
Sep 9, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 8, 2024 04:05PM
Aug 1, 2024 08:00AM BioAtla to Announce Second Quarter 2024 Financial Results and Provide Business Highlights on August 8, 2024
Jul 25, 2024 05:39PM
Jul 23, 2024 08:00AM
May 23, 2024 05:05PM
May 14, 2024 04:05PM
May 8, 2024 08:00AM
May 7, 2024 08:00AM
May 6, 2024 08:02AM BioAtla (BCAB) Announces FDA Clearance of IND Application for BA3361
May 6, 2024 08:00AM
Mar 26, 2024 04:01PM
Dec 5, 2023 08:00AM
Nov 28, 2023 08:00AM
Nov 7, 2023 04:01PM
Aug 1, 2023 04:01PM
Aug 1, 2023 04:01PM BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
May 11, 2023 04:01PM
Mar 23, 2023 04:05PM
Mar 23, 2023 04:05PM
Feb 23, 2023 08:00AM
Feb 23, 2023 08:00AM
Feb 23, 2023 08:00AM
Jan 10, 2023 08:10AM BioAtla (BCAB) Provides Clinical Program Updates and Upcoming 2023 Milestones
Jan 10, 2023 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All